论文部分内容阅读
目的:评价头孢曲松钠与炎琥宁注射液联用治疗急性感染性心内膜炎患者的临床疗效。方法:选取2012年8月—2015年8月间收治的急性感染性心内膜炎患者90例,将其分为对照组和观察组,每组45例;对照组患者均给予头孢曲松钠治疗,观察组患者均给予头孢曲松钠与炎琥宁注射液联用治疗,评价两组患者治疗后的总有效率。结果:观察组患者治疗后的总有效率为97.78%高于对照组为75.56%(P<0.05)。结论:采用头孢曲松钠与炎琥宁注射液联用治疗急性感染性心内膜炎患者的临床疗效优于单用头孢曲松钠的疗效。
Objective: To evaluate the clinical efficacy of ceftriaxone sodium combined with Yanhuning injection in the treatment of patients with acute infectious endocarditis. Methods: Ninety patients with acute infective endocarditis admitted from August 2012 to August 2015 were selected and divided into control group and observation group, with 45 cases in each group. Patients in the control group were given ceftriaxone sodium Patients in the treatment group and the observation group were treated with ceftriaxone and Yanhuning injection, and the total effective rate after treatment was evaluated. Results: The total effective rate after treatment in the observation group was 97.78% higher than that in the control group (75.56%, P <0.05). Conclusion: The clinical efficacy of ceftriaxone sodium and Yanhuning injection in the treatment of patients with acute infectious endocarditis is better than that of ceftriaxone sodium alone.